Salicylic Acid

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the removal of common warts and plantar warts. Common warts are characterized by a rough, 'cauliflower-like' surface appearance, while plantar warts are specifically located on the bottom of the foot, presenting with tenderness and an interruption of the footprint pattern.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be washed thoroughly, and warts may be soaked in warm water for approximately 5 minutes to facilitate treatment. After soaking, the area must be dried completely.

Using the provided applicator, one drop of the medication should be carefully applied to each wart, ensuring that the wart is sufficiently covered. It is important to allow the application to dry completely before proceeding.

This procedure may be repeated once or twice daily as necessary, continuing until the wart is removed, with a maximum treatment duration of up to 12 weeks.

Contraindications

Use of this product is contraindicated in the following situations:

Patients with diabetes or poor blood circulation should not use this product due to the increased risk of complications. Application is also contraindicated on genital warts, warts located on the face, or mucous membranes, as well as on moles, birthmarks, or warts with hair growth. Additionally, the product should not be applied to irritated skin or any area that is infected or exhibits redness.

Warnings and Precautions

For external use only. This product is flammable; it must be kept away from fire or flame to prevent ignition.

The product is contraindicated in individuals with diabetes or poor blood circulation. It should not be applied to genital warts, warts located on the face or mucous membranes, moles, birthmarks, or warts with hair growing from them. Additionally, it must not be used on irritated skin or any area that is infected or reddened.

When using this product, care should be taken to avoid contact with the eyes. In the event of accidental exposure, the eyes should be flushed with water for at least 15 minutes. Users should also avoid inhaling vapors. The bottle should be capped tightly and stored at room temperature, away from heat sources.

If discomfort persists, users are advised to discontinue use and consult a healthcare professional for further evaluation.

This product should be kept out of reach of children. In the case of ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Side Effects

Patients should be aware of several important warnings and precautions associated with the use of this product. It is intended for external use only and is flammable; therefore, it should be kept away from fire or flame.

The product should not be used by individuals who are diabetic or have poor blood circulation. Additionally, it is contraindicated for application on genital warts, warts on the face or mucous membranes, moles, birthmarks, or warts with hair growing from them. It should also not be applied to irritated skin or any area that is infected or reddened.

While using this product, if it comes into contact with the eyes, it is essential to flush the eyes with water for 15 minutes. Users should avoid inhaling vapors and ensure that the bottle is capped tightly and stored at room temperature, away from heat sources.

Patients are advised to stop using the product and consult a doctor if discomfort persists. Furthermore, it is crucial to keep the product out of reach of children. In the event of accidental ingestion, medical help should be sought immediately, or contact with a Poison Control Center should be made.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Salicylic Acid (liquid wart remover). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

The safety of salicylic acid during pregnancy has not been established, as the prescribing information does not provide specific data regarding its use in this population. Consequently, the potential risks to fetal outcomes remain unclear. Healthcare professionals should exercise caution when considering the use of salicylic acid in pregnant patients, as the absence of safety data necessitates a careful evaluation of the benefits versus risks. Women of childbearing potential should be informed of the lack of information and advised to consult their healthcare provider before using salicylic acid during pregnancy.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or its effects on lactation. Additionally, no data are provided concerning the excretion of this medication in breast milk or its potential effects on breastfed infants. Healthcare professionals should consider the lack of information when advising lactating mothers about the use of this medication.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise clinical judgment when considering the use of this medication in patients with liver problems, as the absence of data limits the ability to provide specific recommendations.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical assistance or contact a Poison Control Center without delay.

Prompt action is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action and management strategies.

Healthcare providers should ensure that patients are aware of the importance of timely reporting of any overdosage incidents to facilitate effective treatment and minimize risks.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the understanding of the compound's potential effects in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. Instruct patients that if the product is swallowed, they should seek medical help or contact a Poison Control Center immediately.

It is important to inform patients that this product should not be used by individuals with diabetes or those who have poor blood circulation. Additionally, patients should be cautioned against using the product on genital warts, warts located on the face or mucous membranes, moles, birthmarks, or warts that have hair growing from them.

Patients should also be advised not to apply the product on irritated skin or any area that appears infected or reddened. If discomfort persists after using the product, patients should be instructed to stop use and consult a doctor.

When using this product, healthcare providers should emphasize the following precautions: if the product comes into contact with the eyes, patients should flush the eyes with water for 15 minutes. Patients should also be warned to avoid inhaling vapors. Furthermore, it is essential to remind patients to cap the bottle tightly and store it at room temperature, away from heat sources.

Storage and Handling

The product is supplied in a container that must be stored at a temperature range of 20°C to 25°C (68°F to 77°F). It is essential to close the container tightly after each use to prevent solidification. The top of the bottle should be wiped clean following each application to maintain hygiene and product integrity.

Care should be taken to avoid contact with surrounding skin during application. Additionally, the product should not come into contact with fabrics, floors, countertops, or other surfaces, as it may cause staining. It is also crucial to keep the product away from fire or flame.

The product should be discarded when signs of the wart no longer appear to ensure safety and efficacy.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Salicylic Acid, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)